Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2015

View Archived Issues

Alios Biopharma starts first-in-human study of HCV polymerase inhibitor AL-704

Novavax reports data from phase II trial of quadrivalent seasonal influenza vaccine

arGEN-X and University of Bern to develop ARGX-110-based combination therapies

University of Sydney to study Cymerus stem cells in heart disease models

Heptares to use MorphoSys antibody discovery technology against GPCR target

D-Pharm reports results from pilot trial of DP-b99 in acute pancreatitis

Filgotinib meets key efficacy endpoints in phase IIb DARWIN 1 study

Eisai and Halozyme sign collaboration agreement to investigate eribulin and PEGPH-20

Beijing Normal University patents technetium complexes for imaging

Coferon discloses Bcr-Abl tyrosine-kinase ligands

FDA accepts IND for EDO-S101 in patients with hematologic malignancies and solid tumors

KannaLife Sciences describes neuroprotectants

Aurigene Discovery Technologies divulges IRAK-4 inhibitors

KT&G Life Sciences develops NQO1 modulators

Alios Biopharma starts phase I drug interaction study for AL-335

AstraZeneca and Isis Pharmaceuticals form second antisense therapy collaboration

Sanofi profiles pipeline progress of second quarter 2015

Novel apelin receptor agonist shows promise as vasodilator

Perjeta regimen approved in E.U. for use before surgery in early-stage breast cancer

CTLA4-targeted therapies show promise for the treatment of LRBA deficiency

Allergan's AGN-223575 enters phase II study in dry eye

Biocad initiates phase I trial comparing adalimumab biosimilar to Humira

Anti-GD2 antibody enters phase II trial in osteosarcoma

TiGenix acquires Coretherapix

ORAI1 inhibitors show potential for the treatment of pancreatitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...